Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laquinimod in Active Moderate to Severe Crohn's Disease
NCT00737932Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- May 2010
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of laquinimod in Crohn's disease, sponsored by Teva Pharmaceutical Industries Ltd.. Started May 2010; status: completed.
02
Drugs
laquinimod
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00737932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00737932.